TRAF3 and B-cell non-Hodgkin lymphoma: A recent study, inspired by TRAF3 mutations in canine B-cell lymphoma RNA-seq showed that TRAF3 loss resulting in decreased gene expression is a feature of some human DLBCLs (Bushell et al. 2015).